For example, in melanoma, PRMT5 represses the transcription of genes encoding nucleotide-binding oligomerization domain-like receptor family caspase recruitment domain containing 5 (NLRC5), inhibiting inflammation, and the combination of PRMT5 inhibition and immune checkpoint treatment limited the growth and enhanced the therapeutic effect of melanoma in mice [128]. The gene discussed is PRMT5; the disease is melanoma.